Boiron SA (LON: 0DTF)

Market Cap	400.85M
Revenue (ttm)	408.41M
Net Income (ttm)	20.09M
Shares Out	n/a
EPS (ttm)	1.16
PE Ratio	19.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Average Volume	46
Open	25.35
Previous Close	26.15
Day's Range	25.35 - 27.60
52-Week Range	25.35 - 56.50
Beta	0.48
RSI	56.48
Earnings Date	Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1932
• Employees: 2,810
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.

Financial numbers in EUR